We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
HYOSCINE BUTYLBROMIDE (AFT Pharmaceuticals Pty Ltd)
Product name
HYOSCINE BUTYLBROMIDE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
135 (255 working days)
Active ingredients
Hyoscine butylbromide
Registration type
New generic medicine
Indication
Spasm of the gastrointestinal tract, biliary spasm, renal spasm, diagnostic aid in radiology.